Proteon reports positive results from PRT-201 Phase 2 trial in chronic kidney ... Pharmaceutical Business Review Proteon Therapeutics has reported positive results from Phase 2 trial of PRT-201 conducted in chronic kidney disease (CKD) patients undergoing surgical placement of an arteriovenous fistula (AVF) for hemodialysis. The double-blind, placebo-controlled ... |
